Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

DISEASE CHARACTERISTICS: * Histologically confirmed relapsed or refractory grade I, II, or III non-Hodgkin's lymphoma (NHL), including follicular, small lymphocytic, or marginal zone/MALT lymphoma * Previously treated with radiotherapy, immunotherapy, and/or chemotherapy for NHL * Progression of disease or no response since last treatment for NHL * 1D10+ lymphoma by immunohistochemistry or flow cytometry * Bidimensionally measurable disease at least 2 cm in a single dimension * No CNS metastases * Circulating tumor cells no greater than 5,000/mm\^3 PATIENT CHARACTERISTICS: Age: * 18 and over Performance status: * ECOG 0-2 Life expectancy: * At least 3 months Hematopoietic: * Platelet count at least 75,000/mm\^3 (unless disease related) * Neutrophil count at least 1,000/mm\^3 (unless disease related) * Hemoglobin greater than 8.0 g/dL Hepatic: * Bilirubin less than 2.5 mg/dL * SGOT less than 4 times upper limit of normal Renal: * Creatinine less than 2.5 mg/dL Cardiovascular: * No clinically significant cardiac disease (New York Heart Association class III or IV) * No evidence of myocardial infarction or cardiac arrhythmia (unless surgically repaired) within the past 6 months Pulmonary: * No clinically significant pulmonary disease Other: * No other malignancy within the past 2 years except non-melanoma skin cancer or carcinoma in situ * No significant psychiatric or CNS impairment * No active serious infection * Not pregnant or nursing * Negative pregnancy test * Fertile patients must use effective contraception during and for 1 month after study * Negative anti-Hu1D10 antibody response (HAHA/HAMA) * HIV negative PRIOR CONCURRENT THERAPY: Biologic therapy: * See Disease Characteristics * At least 4 weeks since prior interferon therapy * At least 3 months since prior immunotherapy * No prior monoclonal antibody Hu1D10 Chemotherapy: * See Disease Characteristics * At least 4 weeks since prior cytotoxic chemotherapy Endocrine therapy: * At least 4 weeks since prior corticosteroids (more than 10 mg prednisone/day) * No concurrent corticosteroids at more than 10 mg prednisone/day for pre-existing diseases or adverse reactions Radiotherapy: * See Disease Characteristics * At least 4 weeks since prior external beam radiotherapy * At least 3 months since prior radioimmunotherapy Surgery: * Not specified Other: * No other concurrent lymphoma therapy